The land of Africa is the second largest continent in the world in both square mileage and population. Thus, it also has widespread disease and in turn, is a huge testing bed for new medications and procedures. This week Merck and Qiagen NV have announced collaboration in Rwanda to battle cervical cancer. Rwanda will be […]
VRM: “One For All” Universal Flu Vaccine – 21st Century Genetic Roulette Part 2
By Joel Lord To fully unravel the Biondvax Universal Flu Vaccine scandal, a top down approach is necessary. Professor Ruth Arnon, Ph.D, is the official “inventor of BiondVax’s innovative synthetic influenza vaccine and head of BiondVax’s Scientific Advisory Board“. She is also former “Vice-President of the Weizmann Institute of Science (1988-1997)…an internationally acclaimed immunologist. Along […]
Merck Sharpe and Dohme and Sanofi Pasteur begin new vaccine trial
Posted on 26/04/2011 in Pharmaceutical Company Product News Merck Sharpe and Dohme and its partner Sanofi Pasteur have commenced a clinical study of a new vaccine designed to treat a range of diseases among children. The companies have begun a phase III study of the hexavalent combination vaccine that will test the safety and immunogenicity […]
Merck, Qiagen Begin Rwandan Cervical-Cancer Program, Times Says
By Heather Murdock Merck & Co. and Qiagen NV (QGEN) will fund a program in Rwanda to screen and vaccinate women against cervical cancer, the New Times reported, citing Agnes Binagwaho, permanent secretary in the Health Ministry. Merck will provide more than 2 million doses of its Gardasil vaccine to the government at no charge, […]
Vaccine Mania
The vaccination question is a hotly debated topic, even in the natural health community. It doesn’t help when vaccine companies have blatant conflicts of interest and the studies supporting their safety may be fraudulent! What we all can agree upon is the need to keep crony capitalism out of it, to keep information clear, unambiguous, […]
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 57
- Next Page »
